Breaking News Instant updates and real-time market news.

SNAP

Snap

$11.99

0.46 (3.99%)

, QCOM

Qualcomm

$86.68

4.71 (5.75%)

08:55
04/24/19
04/24
08:55
04/24/19
08:55

Notable open interest changes for April 24th

Tuesday's total option volume of 19.3 million contracts resulted in net open interest growth of 3.69 million calls and 3.60 million puts. Snap Inc. (SNAP), Qualcomm (QCOM), Cenovus Energy (CVE) and Pfizer (PFE) saw the greatest growth. Top five new positions opened include 105k Cenovus Energy (CVE) Jun-19 12 calls, 61k Southwestern Energy (SWN) May-19 3.5 puts, 27k Pfizer (PFE) Sep-19 42 calls, 27k Pfizer (PFE) May-19 37 puts and 27k Pfizer (PFE) Sep-19 44 calls.

SNAP

Snap

$11.99

0.46 (3.99%)

QCOM

Qualcomm

$86.68

4.71 (5.75%)

CVE

Cenovus Energy

$10.44

0.01 (0.10%)

PFE

Pfizer

$39.41

0.44 (1.13%)

  • 24

    Apr

  • 24

    Apr

  • 25

    Apr

  • 30

    Apr

  • 01

    May

  • 02

    May

  • 06

    May

  • 13

    May

  • 18

    May

  • 31

    May

SNAP Snap
$11.99

0.46 (3.99%)

04/24/19
RBCM
04/24/19
NO CHANGE
Target $17
RBCM
Outperform
Snap revenue accelerated in Q1, says RBC Capital
RBC Capital analyst Mark Mahaney kept his Outperform rating and $17 price target on Snap, citing the company's Q1 earnings beat and accelerated 39% revenue growth while noting that its outlook for Q2 suggests a similar rate of growth. The analyst adds that while the management was "somewhat cautious" on daily active user trends for Q2, this could be due to its "conservatism" in guidance. Mahaney contends that his Upgrade call on Snap earlier this month is being confirmed with the quarter's fundamentals - revenue, DAUs, gross margin, EBITDA, free cash flow - all showing improvement.
04/24/19
SBSH
04/24/19
NO CHANGE
Target $14
SBSH
Neutral
Snap results encouraging, but valuation 'appears full,' says Citi
Citi analyst Mark May views Snap's Q1 results as encouraging, but adds its outlook "was more mixed." While the Q2 revenue guidance was only in-line with consensus at the midpoint and adjusted EBITDA was below, the company has recently topped its guidance, which could suggest upside to forecasts, May tells investors in a post-earnings research note. The analyst, however, believes Snap's valuation "appears full." He raised his price target for the shares to $14 from $13 and keeps a Neutral rating on the name.
04/24/19
LEHM
04/24/19
NO CHANGE
Target $14
LEHM
Overweight
Snap price target raised to $14 from $12 at Barclays
Barclays analyst Ross Sandler raised his price target for Snap to $14 from $12 citing the company's "strong performance" in Q1. The analyst keeps an Overweight rating on the shares but admits the "honeymoon may be near the end." While Q1 daily active user net-adds were above buy side expectations at 4M, Snap said that Q2 is likely to drop back down to 0-3M despite Android rolling out to all users worldwide, based on weaker seasonality, Sandler tells investors in a research note. Nonetheless, he keeps an Overweight rating on the shares.
04/24/19
ADAM
04/24/19
NO CHANGE
Target $13
ADAM
Hold
Snap price target raised to $13 from $9.50 at Canaccord
Canaccord analyst Michael Graham raised his price target for Snap to $13 from $9.50, but maintained his Hold rating. After several quarters of challenging user dynamics, Snap's Q1 Daily Active Users grew ~2% sequentially, although were still down year-over-year, Graham tells investors in a research note. However, Graham says that while Snap's revenue performance is encouraging and he is taking a modestly more constructive view on users, he thinks both of these dynamics are already reflected in the stock price.
QCOM Qualcomm
$86.68

4.71 (5.75%)

04/23/19
04/23/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst James Faucette citing his view that the market has "not yet fully appreciated" the impact of the company's settlement with Apple (AAPL), which he thinks not only increases earnings substantially while also expanding the freedom with which Qualcomm can pursue new opportunities. 2. Kimberly-Clark (KMB) upgraded to Buy from Hold at Argus and to Outperform from Neutral at Macquarie. 3. Sanderson Farms (SAFM) upgraded to Neutral from Sell at Goldman Sachs with analyst Adam Samuelson saying African swine fever is upending the protein markets, Samuelson tells investors in a research note. 4. Visteon (VC) upgraded to Outperform from Neutral at Baird while Veoneer (VNE) was upgraded to Neutral from Underperform. 5. Sony (SNE) upgraded to Outperform from Neutral at Macquarie. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/23/19
MSCO
04/23/19
UPGRADE
Target $95
MSCO
Overweight
Morgan Stanley upgrades Qualcomm, thinks Apple pact not yet fully appreciated
As previously reported, Morgan Stanley analyst James Faucette upgraded Qualcomm (QCOM) to Overweight from Equal Weight, citing his view that the market has "not yet fully appreciated" the impact of the company's settlement with Apple (AAPL), which he thinks not only increases earnings substantially while also expanding the freedom with which Qualcomm can pursue new opportunities. Faucette thinks the settlement reinforces two key Qualcomm tenets - the best modem performance matters and that the best intellectual property has value. While he takes a more conservative view than most on the pace of 5G ramp, Faucette said he views Qualcomm as "the key enabler" of 5G technology. He raised his price target on Qualcomm shares to $95 from $55.
04/23/19
MSCO
04/23/19
UPGRADE
MSCO
Overweight
Qualcomm upgraded to Overweight from Equal Weight at Morgan Stanley
04/18/19
04/18/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. PepsiCo (PEP) upgraded to Neutral from Sell at Goldman Sachs with analyst Judy Hong citing its "strong" Q1 results that saw organic revenue accelerate to 5% and gross margins top expectations. 2. J.M. Smucker (SJM) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Pamela Kaufman saying she believes the company's reinvestment strategy will drive improved topline momentum across its key segments and should allow the company to return to positive organic growth in FY20. 3. Venator Materials (VNTR) upgraded to Outperform from Sector Perform at RBC Capital with analyst Arun Viswanathan saying he believes that the titanium dioxide "cycle is turning", with destocking activity nearing completion amid improving global demand and pricing. 4. Ecolab (ECL) upgraded to Buy from Neutral at Nomura Instinet with analyst Dan Dolev saying with the problematic energy business soon to be spun-off, Ecolab's "recession resistant qualities should stand out, warranting a significant premium to peers." 5. Qualcomm (QCOM) upgraded to Buy from Hold at DZ Bank. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CVE Cenovus Energy
$10.44

0.01 (0.10%)

04/16/19
04/16/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Netflix (NFLX) upgraded to Buy from Hold at Deutsche Bank with analyst Bryan Kraft saying consensus subscriber expectations for both 2019 and 2020 now seem conservative. 2. Cenovus Energy (CVE) upgraded to Neutral from Sell at Goldman Sachs with analyst Neil Mehta citing improvements to the company's leverage outlook and a more constructive commodity price environment, particularly for Canadian heavy crude. 3. Cummins (CMI) upgraded to Buy from Neutral at Citi with analyst Timothy Thein saying he sees upside to 2019 estimates and thinks the company's out-year cash flows "stay higher for longer based on end market diversity and increasing contribution from the aftermarket." 4. Western Digital (WDC) upgraded to Buy from Hold at Deutsche Bank with analyst Sidney Ho starting to see favorable data points in both hard disk drive and NAND that will support a "solid" second half of the year recovery for Western Digital's earnings. 5. e.l.f. Beauty (ELF) upgraded to Buy from Neutral at DA Davidson with analyst Linda Bolton Weiser citing the findings of her proprietary store checks suggesting that the company products have seen a 17% increase in shelf space at Target (TGT), overtaking Coty's (COTY) Covergirl brand, while its Q1 sales "inflected from down high-single digits" in Q4 to low-single digits. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/16/19
GSCO
04/16/19
UPGRADE
Target $11
GSCO
Neutral
Cenovus Energy upgraded to Neutral with $11 price target at Goldman Sachs
Goldman Sachs analyst Neil Mehta upgraded Cenovus Energy (CVE) to Neutral from Sell and raised his price target for the shares to $11 from $7.50. The analyst cites improvements to the company's leverage outlook and a more constructive commodity price environment, particularly for Canadian heavy crude, for the upgrade. However, he stills see more upside to Buy-rated ConocoPhillips (COP), Canadian Natural Resources (CNQ), Suncor (SU) and Imperial Oil (IMO) among large cap North American oils than Cenovus.
04/23/19
SBSH
04/23/19
NO CHANGE
SBSH
Neutral
Citi opens '30-Day Upside Catalyst Watch' on Cenovus Energy
Citi analyst Prashant Rao opened a "30-Day Upside Catalyst Watch" on Neutral-rated Cenovus Energy. Stronger price realizations in the upstream due to higher benchmark oil prices and narrowed Canadian differentials could drive "meaningful upside" to Wednesday's Q1 results, Rao tells investors in a research note. The analyst also sees the potential for upward Q2 estimate revisions, helped by "bullish sentiment" for continued upstream price strength in the near-to-intermediate term.
04/16/19
GSCO
04/16/19
UPGRADE
GSCO
Neutral
Cenovus Energy upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Neil Mehta upgraded Cenovus Energy to Neutral from Sell.
PFE Pfizer
$39.41

0.44 (1.13%)

02/26/19
LEHM
02/26/19
NO CHANGE
LEHM
Galapagos weakness could be tied to Pfizer safety alert, says Barclays
Barclays believes the weakness today in Galapagos NV (GLPG) could be attributed to, at least in part, the FDA's safety communication on Pfizer's (PFE) post-marketing study of 10mg daily Xeljanz. Competitor safety issues with higher dose JAK inhibitors was a major focus of Galapagos' post-earnings conference call last week, Barclays tells investors in a research note. Galapagos management, while limited in what it can say pending the data, seems to believe they can get both doses approved, Barclays contends. Further, the firm points out that the company has received no communication and sees no reason to conclude that the FDA has determined that thromboembolic events are a class effect of the JAKs. Shares of Galapagos are down 1.5%, or $1.45, to $97.28 in late morning trading.
02/20/19
02/20/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Pfizer (PFE) resumed with a Neutral from Sell at Citi with analyst Andrew Baum saying the recent pullback in the stock, along with the 5%-8% 2019-2021 consensus estimate reductions, gives him the opportunity to close his Sell rating. 2. Transocean (RIG) and Diamond Offshore (DO) were upgraded to Overweight from Underweight at Barclays. 3. American Axle (AXL) upgraded to Buy from Neutral at BofA/Merrill with analyst John Murphy citing progress with restructuring, GM's (GM) truck cycle, and balance sheet deleveraging. 4. Credit Suisse (CS) upgraded to Hold from Sell at Berenberg. 5. Ipsen (IPSEY) upgraded to Neutral from Sell at Goldman Sachs with analyst Diana Na citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/20/19
SBSH
02/20/19
UPGRADE
Target $41
SBSH
Neutral
Pfizer resumed with a Neutral from Sell at Citi
Citi analyst Andrew Baum resumed coverage of Pfizer following a period of restriction and upgraded the shares to Neutral from Sell. He also boosted his price target for the shares to $41 from $37. The analyst says the recent pullback in the stock, along with the 5%-8% 2019-2021 consensus estimate reductions, gives him the opportunity to close his Sell rating. He believes management action on business development, cost saving or moves to better monetize Pfizer's Established Product business are likely near-term drivers of the stock.
01/31/19
01/31/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Pfizer (PFE) upgraded to Outperform from Neutral at Credit Suisse and to Buy from Hold at Argus. 2. Tiffany (TIF) upgraded to Overweight from Neutral at Atlantic Equities with analyst Daniela Nedialkova saying the pullback has been largely driven by macro concerns while fundamentals of the brand are strong and preliminary FY19 guidance is conservative. 3. Scotts Miracle-Gro (SMG) upgraded to Neutral from Underweight at JPMorgan with analyst Jeffrey Zekauskas citing valuation. 4. Geron (GERN) upgraded to Buy from Neutral at B. Riley FBR with analyst George Zavoico saying he believes investors should focus on the pivotal Phase III trial of imetelstat. 5. Ralph Lauren (RL) upgraded to Outperform from Market Perform at Telsey Advisory with analyst Dana Telsey saying the company's improving sakes, combined with ongoing margin expansion, should bolster its earnings. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

DIS

Disney

$139.71

0.49 (0.35%)

12:42
06/25/19
06/25
12:42
06/25/19
12:42
Periodicals
MNC founder says not in talks with Disney over investment, Reuters says »

Media Nusantara Citra is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

APVO

Aptevo Therapeutics

$0.90

-0.0445 (-4.71%)

12:38
06/25/19
06/25
12:38
06/25/19
12:38
Recommendations
Aptevo Therapeutics analyst commentary  »

Aptevo IXINITY…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TDOC

Teladoc

$62.00

-0.76 (-1.21%)

12:37
06/25/19
06/25
12:37
06/25/19
12:37
Recommendations
Teladoc analyst commentary  »

Teladoc CFO hiring news…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:35
06/25/19
06/25
12:35
06/25/19
12:35
General news
Treasury 2-year auction preview: »

Treasury 2-year auction…

NTDOY

Nintendo

$0.00

(0.00%)

, SNE

Sony

$52.99

-0.16 (-0.30%)

12:34
06/25/19
06/25
12:34
06/25/19
12:34
On The Fly
Game On: May sales slip as GameStop sees demand for new 'Call of Duty' »

NEW RELEASES: This week's…

NTDOY

Nintendo

$0.00

(0.00%)

SNE

Sony

$52.99

-0.16 (-0.30%)

MSFT

Microsoft

$134.60

-3.2 (-2.32%)

SGAMY

Sega Sammy Holdings

$0.00

(0.00%)

GME

GameStop

$5.51

0.14 (2.61%)

ATVI

Activision Blizzard

$46.45

-0.71 (-1.51%)

TTWO

Take-Two

$113.45

-0.39 (-0.34%)

EA

Electronic Arts

$97.22

-1.75 (-1.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 09

    Jul

  • 10

    Jul

  • 06

    Aug

  • 13

    Nov

GOOG

Alphabet

$1,096.47

-19.28 (-1.73%)

, GOOGL

Alphabet Class A

$1,097.35

-19.65 (-1.76%)

12:33
06/25/19
06/25
12:33
06/25/19
12:33
Hot Stocks
Senator Markey urges FTC to require added children's safeguards at YouTube »

Senator Edward J. Marke,…

GOOG

Alphabet

$1,096.47

-19.28 (-1.73%)

GOOGL

Alphabet Class A

$1,097.35

-19.65 (-1.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 10

    Jul

  • 25

    Jul

  • 25

    Jul

  • 27

    Oct

KO

Coca-Cola

$51.97

0.045 (0.09%)

12:30
06/25/19
06/25
12:30
06/25/19
12:30
Hot Stocks
American Dream announces 10-year partnership with Coca-Cola »

American Dream announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

MOS

Mosaic

$24.23

0.8 (3.41%)

12:25
06/25/19
06/25
12:25
06/25/19
12:25
Options
Mosaic call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

12:25
06/25/19
06/25
12:25
06/25/19
12:25
Conference/Events
William Blair financial services/insurance analyst to hold a luncheon »

Financial…

CLXT

Calyxt

$12.42

-0.13 (-1.04%)

12:25
06/25/19
06/25
12:25
06/25/19
12:25
Conference/Events
Calyxt to host investor & analyst day »

Investor & Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

12:19
06/25/19
06/25
12:19
06/25/19
12:19
Conference/Events
Morgan Stanley energy analysts to hold an analyst/industry conference call »

Analysts discuss PJM…

JPM

JPMorgan

$108.71

0.05 (0.05%)

, BAC

Bank of America

$27.67

-0.31 (-1.11%)

12:19
06/25/19
06/25
12:19
06/25/19
12:19
Periodicals
JPMorgan CEO says 'going right at' BofA in branch expansion, Bloomberg says »

JPMorgan (JPM) CEO Jamie…

JPM

JPMorgan

$108.71

0.05 (0.05%)

BAC

Bank of America

$27.67

-0.31 (-1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 17

    Jul

  • 06

    Aug

MMTOF

Mitsubishi Motors

$0.00

(0.00%)

12:19
06/25/19
06/25
12:19
06/25/19
12:19
Hot Stocks
Mitsubishi Motors North America relocating U.S. headquarters to Tennessee »

Mitsubishi Motors North…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
06/25/19
06/25
12:17
06/25/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
06/25/19
06/25
12:16
06/25/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STM

STMicroelectronics

$16.87

-0.155 (-0.91%)

12:15
06/25/19
06/25
12:15
06/25/19
12:15
Options
STMicroelectronics put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UMC

UMC

$2.18

0.03 (1.40%)

12:14
06/25/19
06/25
12:14
06/25/19
12:14
Upgrade
UMC rating change  »

UMC upgraded two notches…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

12:10
06/25/19
06/25
12:10
06/25/19
12:10
General news
FX Action: USD-JPY »

FX Action: USD-JPY fell…

AGN

Allergan

$164.20

34.55 (26.65%)

, ABBV

AbbVie

$66.78

-11.63 (-14.83%)

12:08
06/25/19
06/25
12:08
06/25/19
12:08
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks have slid in…

AGN

Allergan

$164.20

34.55 (26.65%)

ABBV

AbbVie

$66.78

-11.63 (-14.83%)

TMUS

T-Mobile

$74.93

-0.61 (-0.81%)

S

Sprint

$6.86

(0.00%)

DISH

Dish

$37.93

-0.66 (-1.71%)

LEN

Lennar

$48.75

-2.66 (-5.17%)

PYX

Pyxus

$16.70

3.28 (24.44%)

GRUB

GrubHub

$75.31

3.26 (4.52%)

ALDX

Aldeyra

$5.85

-1.23 (-17.37%)

BHF

Brighthouse Financial

$32.74

-5.36 (-14.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 27

    Jun

  • 27

    Jun

  • 28

    Jun

  • 09

    Jul

  • 16

    Sep

DLTR

Dollar Tree

$109.86

-2.86 (-2.54%)

12:08
06/25/19
06/25
12:08
06/25/19
12:08
Hot Stocks
Dollar Tree director Thomas Saunders sells over $1.6M in company shares »

Dollar Tree director…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSRM

SSR Mining

$13.72

-0.2 (-1.44%)

12:05
06/25/19
06/25
12:05
06/25/19
12:05
Options
SSR Mining call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALDX

Aldeyra

$5.85

-1.23 (-17.37%)

12:02
06/25/19
06/25
12:02
06/25/19
12:02
Recommendations
Aldeyra analyst commentary at Stifel »

Stifel says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

UNH

UnitedHealth

$249.06

-0.59 (-0.24%)

12:00
06/25/19
06/25
12:00
06/25/19
12:00
Periodicals
UnitedHealth buys PatientsLikeMe after scrutiny over Chinese investor, CNBC says »

According to a story out…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

RGS

Regis

$16.62

-1.15 (-6.47%)

12:00
06/25/19
06/25
12:00
06/25/19
12:00
Hot Stocks
Regis falls -6.4% »

Regis is down -6.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQT

EQT Corporation

$14.36

-1.02 (-6.63%)

12:00
06/25/19
06/25
12:00
06/25/19
12:00
Hot Stocks
EQT Corporation falls -6.6% »

EQT Corporation is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.